en

PRODUCT DETAIL

YLPIO 80 mg/2,5 mg tablety

Code 6612D
MA number 58/0034/21-S
Product Form: tbl 100x80 mg/2,5 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DA Angiotensin II antagonists and diuretics
C09DA07 TELMISARTAN AND DIURETICS
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 08.02.2021
Validity: 08.02.2026
SPC: SPC_Ylpio_10/2022.pdf  
PIL: PIL_Ylpio_10_2022.pdf  
Safety feature Yes
Data update: 27.05.2021
eu-flag.png sk-flag.png